Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

European Stocks Lower on U.S. Inflation Fears; Hugo Boss Shines

Published 14/07/2021, 09:18
Updated 14/07/2021, 09:18
© Reuters.

By Peter Nurse 

Investing.com - European stock markets weakened Wednesday, as a jump in U.S. inflation raised concerns the Federal Reserve could tighten its ultra-easy monetary policies sooner than previously expected.

At 3:55 AM ET (0855 GMT), the DAX in Germany traded 0.2% lower, the CAC 40 in France fell 0.2% and the U.K.’s FTSE 100 dropped 0.4%.

This cautious tone in Europe follows weakness in Asia and also on Wall Street overnight after data released Tuesday showed the U.S. consumer price index jumped 0.9% in June, climbing 5.4% on the year, the biggest jump in U.S. inflation in 13 years.

“Yet another blowout inflation reading makes it increasingly difficult for the Fed to stick to its position that elevated inflation readings are merely ‘transitory’,” said analysts at ING, in a note. “The case for a 2022 rate hike is strong.”

Prices are also rising in Europe, with U.K. inflation climbing 0.5% in June, a gain of 2.5% on the year, and the strongest reading since 2018. Spain and Slovakia also reported CPIs above expectations for June.

Later in the session, investors will carefully study comments from Fed Chairman Jerome Powell in his two-day semi-annual testimony to Congress for any sign that the latest numbers have changed his thinking.  

The second-quarter earnings season continues in the U.S. Wednesday, with Bank of America (NYSE:BAC), Citigroup (NYSE:C) and Wells Fargo (NYSE:WFC) all due to update before the market opens. 

In Europe, Hugo Boss (DE:BOSSn) stock rose over 6% after the German fashion retailer forecast a jump in its annual revenue of between 30% and 35%. Tele2 (ST:TEL2b) stock also climbed 5% after the Swedish telecoms operator reported a rise of 8% in quarterly core earnings.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Additionally, AstraZeneca's (NASDAQ:AZN) $39 billion buyout of U.S.-based rare diseases business Alexion (NASDAQ:ALXN) is expected to close next week as Britain's competition watchdog cleared the deal.

Elsewhere, oil prices edged lower Wednesday after China’s crude imports fell 3% in the first half of the year, raising concerns about slowing demand at the world’s top importer.

However, the market remains elevated, closing Tuesday at the highest level since October 2018, after the American Petroleum Institute reported that crude inventories slid by more than 4 million barrels last week. This would be an eighth straight weekly draw, the longest run of declines since January 2018, if confirmed by government figures later on Wednesday. 

At 3:55 AM ET, U.S. crude futures traded 0.3% lower at $75.04 a barrel, after climbing 1.6% Tuesday, while the Brent contract fell 0.2% to $76.31, after gaining 1.8% in the previous session.

Additionally, gold futures rose 0.2% to $1,812.55/oz, while EUR/USD traded 0.1% higher at 1.1787.

 

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.